CME Group Inc (NASDAQ: CME) has a price-to-earnings ratio of 25.88x that is above its average ratio. Additionally, the 36-month beta value for CME is 0.55. There are mixed opinions on the stock, with 4 analysts rating it as a “buy,” 1 rating it as “overweight,” 10 rating it as “hold,” and 0 rating it as “sell.”
The public float for CME is 355.41M and currently, short sellers hold a 1.26% ratio of that float. The average trading volume of CME on February 12, 2025 was 2.09M shares.
CME) stock’s latest price update
CME Group Inc (NASDAQ: CME)’s stock price has gone rise by 1.81 in comparison to its previous close of 241.74, however, the company has experienced a 1.85% increase in its stock price over the last five trading days. zacks.com reported 2025-02-12 that The headline numbers for CME (CME) give insight into how the company performed in the quarter ended December 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
CME’s Market Performance
CME Group Inc (CME) has seen a 1.85% rise in stock performance for the week, with a 7.26% gain in the past month and a 11.77% surge in the past quarter. The volatility ratio for the week is 1.25%, and the volatility levels for the past 30 days are at 1.53% for CME. The simple moving average for the last 20 days is 3.72% for CME’s stock, with a simple moving average of 15.38% for the last 200 days.
Analysts’ Opinion of CME
Many brokerage firms have already submitted their reports for CME stocks, with Citigroup repeating the rating for CME by listing it as a “Neutral.” The predicted price for CME in the upcoming period, according to Citigroup is $250 based on the research report published on January 06, 2025 of the current year 2025.
Redburn Atlantic, on the other hand, stated in their research note that they expect to see CME reach a price target of $244. The rating they have provided for CME stocks is “Neutral” according to the report published on October 08th, 2024.
RBC Capital Mkts gave a rating of “Sector Perform” to CME, setting the target price at $235 in the report published on September 27th of the previous year.
CME Trading at 5.19% from the 50-Day Moving Average
After a stumble in the market that brought CME to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -0.25% of loss for the given period.
Volatility was left at 1.53%, however, over the last 30 days, the volatility rate increased by 1.25%, as shares surge +6.41% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +3.90% upper at present.
During the last 5 trading sessions, CME rose by +2.05%, which changed the moving average for the period of 200-days by +16.02% in comparison to the 20-day moving average, which settled at $237.31. In addition, CME Group Inc saw 5.98% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at CME starting from SHEPARD WILLIAM R, who purchase 1,369 shares at the price of $227.96 back on Jan 16 ’25. After this action, SHEPARD WILLIAM R now owns 256,805 shares of CME Group Inc, valued at $312,041 using the latest closing price.
SHEPARD WILLIAM R, the Director of CME Group Inc, purchase 60 shares at $227.96 during a trade that took place back on Jan 16 ’25, which means that SHEPARD WILLIAM R is holding 2,432 shares at $13,757 based on the most recent closing price.
Stock Fundamentals for CME
Current profitability levels for the company are sitting at:
- 0.64 for the present operating margin
- 0.86 for the gross margin
The net margin for CME Group Inc stands at 0.57. The total capital return value is set at 0.1. Equity return is now at value 12.30, with 2.63 for asset returns.
Based on CME Group Inc (CME), the company’s capital structure generated 0.11 points at debt to capital in total, while cash flow to debt ratio is standing at 1.08. The debt to equity ratio resting at 0.12. The interest coverage ratio of the stock is 24.06.
Currently, EBITDA for the company is 3.79 billion with net debt to EBITDA at 0.25. When we switch over and look at the enterprise to sales, we see a ratio of 14.85. The receivables turnover for the company is 9.6for trailing twelve months and the total asset turnover is 0.04.
Conclusion
In conclusion, CME Group Inc (CME) has seen better performance in recent times. Analysts have a bullish opinion on the stock, with some rating it as a “buy” and others rating it as a “hold”. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
